Mesa Laboratories Q1 Adj. EPS $1.77 Beats $1.67 Estimate, Sales $50.65M Miss $51.85M Estimate
Portfolio Pulse from Benzinga Newsdesk
Mesa Laboratories (NASDAQ:MLAB) reported Q1 adjusted earnings of $1.77 per share, beating the analyst consensus estimate of $1.67 by 5.99%. However, the company's quarterly sales of $50.65 million missed the analyst consensus estimate of $51.85 million by 2.32%.
August 04, 2023 | 1:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mesa Laboratories reported better than expected Q1 earnings but missed on sales estimates.
While the company beat earnings estimates, which is a positive signal, it missed on sales estimates, which could be a concern for investors. The net impact could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100